Millions of Americans between 45 and 49 could soon face a new decision at their doctor’s office after U.S. health officials ...

Older adults who received the recombinant shingles vaccine known as Shingrix showed a lower rate of new dementia diagnoses ...

Receipt of a newer recombinant version of a shingles vaccine is associated with a significant delay in dementia diagnosis in older adults, a new study suggests. The study builds on previous ...

Please provide your email address to receive an email when new articles are posted on . Recombinant herpes zoster vaccine recipients had lower risk for developing dementia compared with those who ...

But there is an effective way to prevent shingles: the recombinant zoster vaccine (Shingrix), that requires two injections in the upper arm, given between two and six months apart. Shingles ...

The recombinant zoster vaccine (Shingrix) was associated with a 17% increase in time without a dementia diagnosis, compared with the live vaccine. This translated into 164 additional days without a ...

More than 80% of immunosuppressed patients with idiopathic inflammatory myopathy achieved seroconversion after receiving the ...